FOUND: 12 | Mind Blowing Facts

Trade stand-off continues as US drug tariffs loom

The deadline on US pharmaceutical tariffs has been dramatically brought forward, in the latest escalation of Donald Trump's trade war with the world.

AAP · Jul 19, 2025

Bristol‑Myers Squibb, Pfizer Set To Launch Direct‑To‑Patient Eliquis At 40% Off

The Bristol Myers Squibb Co. (NYSE:BMY) and Pfizer Inc. (NYSE:PFE) alliance announced a new direct-to-patient option for purchasing Eliquis (apixaban) via the alliance’s patient resource, Eliquis 360 Support, on Thursday.

Benzinga · Jul 17, 2025

Retirement Ready: 3 Dividend Stocks to Set and Forget

These are three rock-solid dividend stocks you can buy now and confidently forget, knowing they’ll keep working for you year after year.

Barchart · Jul 15, 2025

Wednesday’s Unusual Options Activity Reveals 3 Standout Long Straddle Plays

There were 37 unusually active options in Wednesday Trading that expire in 30 days. This DTE reveals three standout long straddle plays that provide a nice combination of time and cost, while allowing increased volatility to take its course.

Barchart · Jul 10, 2025

Ursula von der Leyen faces confidence vote in far-right challenge

A range of accusations have been levelled against the European Commission president

The Independent UK · Jul 10, 2025

Von der Leyen survives censure vote but faces calls to reverse EU’s rightward drift

Debate on motion against European Commission president lifts lid on simmering discontent among MEPs

The Guardian - UK · Jul 10, 2025

Pfizer Earnings Preview: What to Expect

Pfizer is expected to announce its second-quarter results next month, and analysts predict a single-digit drop in the company’s bottom-line figure.

Barchart · Jul 9, 2025

Top 5 Undervalued Dividend Stocks With Strong Payout Potential

Seemingly undervalued dividend stocks, such as BAC, F, MO, VZ, and PFE, offer a rare combination of strong yields and attractive valuations.

MarketBeat · Jul 7, 2025

Regulator warns of small risk of serious condition in people having RSV jab

Guillain-Barre syndrome is a rare but serious condition which needs urgent treatment in hospital to prevent it progressing.

Evening Standard · Jul 7, 2025

Turbulent research landscape imperils US brain gain − and ultimately American prosperity

Despite representing only 4% of the world’s population, the United States accounts for over half of science Nobel Prizes awarded since 2000, hosts seven of The Times Higher Education Top 10 science universities, and incubates firms such as Alphabet (Google), Meta and Pfizer that turn federally funded discoveries into billion-dollar…

The Conversation · Jul 7, 2025